SCHEMBL201370

SCHEMBL201370

BrCc1nc2cc(Br)ccc2s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.46
TRPV1 Q8NER1 2/20 0.45
LOXL2 Q9Y4K0 1/20 0.45
AKR1B1 P15121 3/20 0.43
PPARA Q07869 2/20 0.42
HDAC6 Q9UBN7 3/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
GAA P10253 2/20 0.41
MAPK1 P28482 1/20 0.41
MGAM O43451 1/20 0.40
SI P14410 1/20 0.40
MGAM2 Q2M2H8 1/20 0.40
ADORA1 P30542 1/20 0.39
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27281641 0.86 DYRK1A (0.44) DYRK1ATRPV1LOXL2AKR1B1PPARA
SCHEMBL9320873 0.85 RAB9A (0.49) DYRK1AAKR1B1PPARANPC1RAB9A
SCHEMBL9675635 0.84 LOXL2 (0.47) DYRK1ATRPV1LOXL2AKR1B1PPARA
SCHEMBL2947099 0.84 NPC1 (0.63) DYRK1ATRPV1LOXL2AKR1B1PPARA
SCHEMBL31003151 0.84 NPC1 (0.63) DYRK1ATRPV1LOXL2AKR1B1PPARA
SCHEMBL3247063 0.84 LOXL2 (0.65) DYRK1ATRPV1LOXL2AKR1B1PPARA
Iodide SCHEMBL31511840 0.82 LOXL2 (0.63) DYRK1ATRPV1LOXL2AKR1B1PPARA
Hydrochloric Acid SCHEMBL29456890 0.82 LOXL2 (0.63) DYRK1ATRPV1LOXL2AKR1B1PPARA
Hydrochloric Acid SCHEMBL20511957 0.82 LOXL2 (0.63) DYRK1ATRPV1LOXL2AKR1B1PPARA
SCHEMBL5946247 0.81 DYRK1A (0.47) DYRK1ATRPV1LOXL2AKR1B1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250179008-A1 ANTIBACTERIAL AGENTS TAXIS PHARMACEUTICALS, INC. (US) 2025-06-05 US disclosed
US-9428528-B2 Phenicol antibacterials ZOETIS SERVICES LLC (US) 2016-08-30 US disclosed
US-9428528-B2 Phenicol antibacterials ZOETIS SERVICES LLC (US) 2016-08-30 US disclosed
US-9428528-B2 Phenicol antibacterials ZOETIS SERVICES LLC (US) 2016-08-30 US disclosed
US-20160194342-A1 PHENICOL ANTIBACTERIALS ZOETIS SERVICES LLC (US) 2016-07-07 US disclosed
US-20160194342-A1 PHENICOL ANTIBACTERIALS ZOETIS SERVICES LLC (US) 2016-07-07 US disclosed
US-20160194342-A1 PHENICOL ANTIBACTERIALS ZOETIS SERVICES LLC (US) 2016-07-07 US disclosed
US-9340564-B2 Phenicol antibacterials ZOETIS SERVICES LLC (US) 2016-05-17 US disclosed
US-9340564-B2 Phenicol antibacterials ZOETIS SERVICES LLC (US) 2016-05-17 US disclosed
US-9340564-B2 Phenicol antibacterials ZOETIS SERVICES LLC (US) 2016-05-17 US disclosed
WO-2007107758-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2007-09-27 WO disclosed
WO-2007107758-A1 ANTIBACTERIAL AGENTS PROLYSIS LTD (GB) 2007-09-27 WO disclosed
US-5330997-A 1H-indazole-3-acetic acids as aldose reductase inhibitors PFIZER INC. (US) 1994-07-19 US disclosed
US-5236945-A 1H-indazole-3-acetic acids as aldose reductase inhibitors PFIZER INC. (US) 1993-08-17 US disclosed
EP-0325375-B1 1H-INDAZOLE-3-ACETIC ACIDS AS ALDOSE REDUCTASE INHIBITORS PFIZER INC. (US) 1992-08-12 EP disclosed
EP-0222576-B1 HETEROCYCLIC OXOPHTHALAZINYL ACETIC ACIDS PFIZER INC. (US) 1992-03-18 EP disclosed
US-4939140-A ALDOSE REDUCTASE INHIBITORS PFIZER INC. (US) 1990-07-03 US disclosed
WO-1989006651-A1 1H-INDAZOLE-3-ACETIC ACIDS AS ALDOSE REDUCTASE INHIBITORS PFIZER INC. (US) 1989-07-27 WO disclosed
EP-0325375-A1 1H-indazole-3-acetic acids as aldose reductase inhibitors PFIZER INC. (US) 1989-07-26 EP disclosed
EP-0222576-A2 Heterocyclic oxophthalazinyl acetic acids PFIZER INC. (US) 1987-05-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160194342-A1 PHENICOL ANTIBACTERIALS MRPL21, TTL, CTSL DYRK1A 2301/4885TRPV1 1655/4885LOXL2 38/4885
US-20250179008-A1 ANTIBACTERIAL AGENTS ALK, ROS1, NOX1 DYRK1A 4146/4885TRPV1 3827/4885LOXL2 1520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.